Glenmark Pharmaceuticals Ltd.

NSE: GLENMARK | BSE: 532296

Expensive Underperformer

Download real time

1420.90 8.40 (0.59%)

44.22% Gain from 52W Low

1.4M NSE+BSE Volume

NSE 24 Apr, 2025 3:31 PM (IST)

40,097.9

Market Cap

High in industry

0.9

Beta 1Year

Low volatility

Glenmark Pharmaceuticals Ltd. - GLENMARK - stock price prediction, stock forecast, target price, analyst ratings from 12 analysts

Glenmark Pharmaceuticals Ltd. has a share price target of Rs 1691, revenue growth forecast of 13.9%, and profit growth estimate of 191.7% for FY25, based on top 12 analyst calls.

Forecaster Screeners